RSS   Newsletter   Contact   Advertise with us

Primex Pharmaceuticals appoints Dan Spacie as global commercial head

Christian Fernsby | Zug, Switzerland | October 24, 2019
Dan SpaciePrimex Pharmaceuticals AG, an anaesthesia products company, announces the appointment of Dan Spacie as global commercial head, effective September 24, 2019.
Mr. Spacie has joined Primex Pharmaceuticals from Syneos Health, where he was President, Commercial, Europe.

Prior to Syneos, Mr. Spacie held several leadership roles including Managing Director at STADA UK affiliates for 5 years.

Mr. Spacie has extensive international leadership experience in growing sales and enhancing profitability of generics, branded pharmaceuticals and launching biopharmaceuticals.

At Primex, he is responsible for global Commercialisation working with both our partners and direct field forces across the portfolio and with the launch of OZALIN in EU.

He will be part of the Executive Team.